NR 607 FINAL EXAM PREP – DIAGNOSIS &
MANAGEMENT IN PSYCHIATRIC-MENTAL
HEALTH PRACTICUM III – (2026) ACTUAL
QUESTIONS & ANSWERS (CHAMBERLAIN)
100% GUARANTEE PASS
Core Domains
Psychiatric Assessment and Differential Diagnosis
Psychopharmacology – Antidepressants, Antipsychotics, Mood Stabilizers,
Anxiolytics, Stimulants
DSM-5-TR Diagnostic Criteria – Mood, Anxiety, Psychotic, Trauma, and
OCD Spectrum Disorders
Psychiatric Emergencies and Crisis Intervention
Suicide Risk Assessment and Safety Planning
Therapeutic Modalities and Psychotherapy Interventions
Trauma-Informed Care and Complex Trauma
Legal, Ethical, and Professional Standards in PMHNP Practice
Social Determinants of Health and Health Equity
Patient Education, Treatment Planning, and Follow-up
Introduction
This comprehensive final examination review is designed for students
preparing for the NR 607 Diagnosis & Management in Psychiatric-Mental
Health III Practicum examination at Chamberlain University. The exam
assesses advanced practice nursing students' ability to synthesize clinical
management skills for complex psychiatric mental health populations
across the lifespan. Emphasis is placed on differential diagnosis, evidence-
based psychopharmacology, psychotherapy interventions, crisis
intervention, legal and ethical considerations, and treatment planning. The
100 multiple-choice and clinical vignette questions are structured to
evaluate critical thinking, clinical decision-making, and the ability to apply
advanced psychiatric principles to real-world patient scenarios. Each
,question is accompanied by a detailed rationale to reinforce learning and
clarify the underlying clinical reasoning. This review serves as an essential
tool for examination preparation and professional practice in the
psychiatric-mental health nurse practitioner role.
SECTION ONE: QUESTIONS 1–100
1. Which neurotransmitter is primarily implicated in the
pathophysiology of schizophrenia?
A. Norepinephrine
B. Serotonin
C. Dopamine
D. Acetylcholine
C. Dopamine
RATIONALE: The dopamine hypothesis suggests that
hyperdopaminergic activity in the mesolimbic pathway contributes to
the positive symptoms of schizophrenia. While other neurotransmitters
are involved, dopamine remains the primary target of antipsychotic
medications.
2. A patient presents with flashbacks, hypervigilance, and
avoidance of reminders of a traumatic event that occurred six
months ago. Which diagnosis is most consistent with these
symptoms?
A. Generalized anxiety disorder
B. Post-traumatic stress disorder
C. Acute stress disorder
D. Obsessive-compulsive disorder
B. Post-traumatic stress disorder
RATIONALE: PTSD is characterized by exposure to a traumatic event
followed by intrusion symptoms (flashbacks), avoidance, negative
,alterations in cognition and mood, and hyperarousal. Symptoms must
persist for more than one month.
3. The spouse of your patient asks you to describe how Donepezil
helps her husband who has mild Alzheimer's disease. Which of the
following is the best response?
A. Donepezil helps prevent the breakdown of acetylcholine
B. Donepezil blocks dopamine receptors to reduce agitation
C. Donepezil cures Alzheimer's disease by reversing plaques
D. Donepezil increases serotonin levels to improve mood
A. Donepezil helps prevent the breakdown of acetylcholine
RATIONALE: Donepezil is an acetylcholinesterase inhibitor. It
increases acetylcholine availability in the synaptic cleft, which may
temporarily improve or stabilize cognition in mild to moderate
Alzheimer disease, but it does not cure the disease.
4. A 47-year-old female inmate presents with dizziness when
bending over and persistent fatigue. She believes she has multiple
sclerosis based on internet research and a friend's diagnosis.
Medical tests (CT, MRI, vestibular testing) are negative. What is
the most likely diagnosis?
A. Somatic symptom disorder
B. Illness anxiety disorder
C. Malingering
D. Factitious disorder
B. Illness anxiety disorder
RATIONALE: Illness anxiety disorder is characterized by excessive
worry about having a serious illness despite minimal or no symptoms
and negative medical evaluations. The patient's focus on multiple
sclerosis, internet research, and persistent concern despite normal tests
align with this diagnosis.
, 5. Which of the following best describes pharmacodynamics?
A. How the body affects the drug
B. How the drug affects the body
C. The study of drug absorption
D. The study of drug metabolism
B. How the drug affects the body
RATIONALE: Pharmacodynamics describes what the drug does to
the body, including mechanisms of action, receptor binding, and dose-
response relationships. Pharmacokinetics describes what the body does
to the drug.
6. What is the primary mechanism of action of selective serotonin
reuptake inhibitors (SSRIs)?
A. Block the serotonin transporter (SERT), increasing synaptic serotonin
levels
B. Block the norepinephrine transporter, increasing synaptic
norepinephrine levels
C. Inhibit monoamine oxidase enzyme, preventing serotonin
degradation
D. Act as direct agonists at postsynaptic 5-HT1A receptors
A. Block the serotonin transporter (SERT), increasing synaptic
serotonin levels
RATIONALE: SSRIs selectively inhibit the serotonin transporter
(SERT), increasing serotonin availability in the synaptic cleft. This
mechanism underlies their first-line status for MDD and GAD per APA
practice guidelines.
7. A client who is having active visual hallucinations currently has a
lighter and a pocketknife in his possession. Which AEIO risk
assessment category is correctly assigned for this client?
MANAGEMENT IN PSYCHIATRIC-MENTAL
HEALTH PRACTICUM III – (2026) ACTUAL
QUESTIONS & ANSWERS (CHAMBERLAIN)
100% GUARANTEE PASS
Core Domains
Psychiatric Assessment and Differential Diagnosis
Psychopharmacology – Antidepressants, Antipsychotics, Mood Stabilizers,
Anxiolytics, Stimulants
DSM-5-TR Diagnostic Criteria – Mood, Anxiety, Psychotic, Trauma, and
OCD Spectrum Disorders
Psychiatric Emergencies and Crisis Intervention
Suicide Risk Assessment and Safety Planning
Therapeutic Modalities and Psychotherapy Interventions
Trauma-Informed Care and Complex Trauma
Legal, Ethical, and Professional Standards in PMHNP Practice
Social Determinants of Health and Health Equity
Patient Education, Treatment Planning, and Follow-up
Introduction
This comprehensive final examination review is designed for students
preparing for the NR 607 Diagnosis & Management in Psychiatric-Mental
Health III Practicum examination at Chamberlain University. The exam
assesses advanced practice nursing students' ability to synthesize clinical
management skills for complex psychiatric mental health populations
across the lifespan. Emphasis is placed on differential diagnosis, evidence-
based psychopharmacology, psychotherapy interventions, crisis
intervention, legal and ethical considerations, and treatment planning. The
100 multiple-choice and clinical vignette questions are structured to
evaluate critical thinking, clinical decision-making, and the ability to apply
advanced psychiatric principles to real-world patient scenarios. Each
,question is accompanied by a detailed rationale to reinforce learning and
clarify the underlying clinical reasoning. This review serves as an essential
tool for examination preparation and professional practice in the
psychiatric-mental health nurse practitioner role.
SECTION ONE: QUESTIONS 1–100
1. Which neurotransmitter is primarily implicated in the
pathophysiology of schizophrenia?
A. Norepinephrine
B. Serotonin
C. Dopamine
D. Acetylcholine
C. Dopamine
RATIONALE: The dopamine hypothesis suggests that
hyperdopaminergic activity in the mesolimbic pathway contributes to
the positive symptoms of schizophrenia. While other neurotransmitters
are involved, dopamine remains the primary target of antipsychotic
medications.
2. A patient presents with flashbacks, hypervigilance, and
avoidance of reminders of a traumatic event that occurred six
months ago. Which diagnosis is most consistent with these
symptoms?
A. Generalized anxiety disorder
B. Post-traumatic stress disorder
C. Acute stress disorder
D. Obsessive-compulsive disorder
B. Post-traumatic stress disorder
RATIONALE: PTSD is characterized by exposure to a traumatic event
followed by intrusion symptoms (flashbacks), avoidance, negative
,alterations in cognition and mood, and hyperarousal. Symptoms must
persist for more than one month.
3. The spouse of your patient asks you to describe how Donepezil
helps her husband who has mild Alzheimer's disease. Which of the
following is the best response?
A. Donepezil helps prevent the breakdown of acetylcholine
B. Donepezil blocks dopamine receptors to reduce agitation
C. Donepezil cures Alzheimer's disease by reversing plaques
D. Donepezil increases serotonin levels to improve mood
A. Donepezil helps prevent the breakdown of acetylcholine
RATIONALE: Donepezil is an acetylcholinesterase inhibitor. It
increases acetylcholine availability in the synaptic cleft, which may
temporarily improve or stabilize cognition in mild to moderate
Alzheimer disease, but it does not cure the disease.
4. A 47-year-old female inmate presents with dizziness when
bending over and persistent fatigue. She believes she has multiple
sclerosis based on internet research and a friend's diagnosis.
Medical tests (CT, MRI, vestibular testing) are negative. What is
the most likely diagnosis?
A. Somatic symptom disorder
B. Illness anxiety disorder
C. Malingering
D. Factitious disorder
B. Illness anxiety disorder
RATIONALE: Illness anxiety disorder is characterized by excessive
worry about having a serious illness despite minimal or no symptoms
and negative medical evaluations. The patient's focus on multiple
sclerosis, internet research, and persistent concern despite normal tests
align with this diagnosis.
, 5. Which of the following best describes pharmacodynamics?
A. How the body affects the drug
B. How the drug affects the body
C. The study of drug absorption
D. The study of drug metabolism
B. How the drug affects the body
RATIONALE: Pharmacodynamics describes what the drug does to
the body, including mechanisms of action, receptor binding, and dose-
response relationships. Pharmacokinetics describes what the body does
to the drug.
6. What is the primary mechanism of action of selective serotonin
reuptake inhibitors (SSRIs)?
A. Block the serotonin transporter (SERT), increasing synaptic serotonin
levels
B. Block the norepinephrine transporter, increasing synaptic
norepinephrine levels
C. Inhibit monoamine oxidase enzyme, preventing serotonin
degradation
D. Act as direct agonists at postsynaptic 5-HT1A receptors
A. Block the serotonin transporter (SERT), increasing synaptic
serotonin levels
RATIONALE: SSRIs selectively inhibit the serotonin transporter
(SERT), increasing serotonin availability in the synaptic cleft. This
mechanism underlies their first-line status for MDD and GAD per APA
practice guidelines.
7. A client who is having active visual hallucinations currently has a
lighter and a pocketknife in his possession. Which AEIO risk
assessment category is correctly assigned for this client?
